Pifithrin-α (CAS: 63208-82-2)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51816-1ML | In Stock | 1mL(10mM in DMSO) | £97.90 | |
EBC51816-5MG | In Stock | 5mg | £53.90 | |
EBC51816-10MG | In Stock | 10mg | £86.90 | |
EBC51816-25MG | In Stock | 25mg | £185.90 | |
EBC51816-50MG | In Stock | 50mg | £284.90 |
Please Select The Country You Are In To Find Your Local Distributor. |
CUlabSciences | Phone:+44 (0) 1232 330008 | |
Cambridge House St Thomas' Place Ely, | E-mail:sales@culabsciences.co.uk | |
United Kingdom | Cambridge CB27 9RD UK | Web:www.culabsciences.co.uk |
Product Information | |||||||||||||||||||||
Synonym(s) | PFT-α, PFTα hydrobromide, Pifithrin hydrobromide, Pifithrin-α | ||||||||||||||||||||
Chemical Name | 2-(2-Imino-4,5,6,7-tetrahydrobenzothiazol-3-yl)-1- p-tolylethanone | ||||||||||||||||||||
Application | Pifithrin-α is an inhibitor of p53 | ||||||||||||||||||||
CAS Number | 63208-82-2 | ||||||||||||||||||||
Purity | ≥98.0% | ||||||||||||||||||||
Molecular Weight | 367.30 | ||||||||||||||||||||
Molecular Formula | C₁₆H₁₉BrN₂OS | ||||||||||||||||||||
SMILES | CC1=CC=C(C=C1)C(=O)CN2C3=C(CCCC3)SC2=N.Br | ||||||||||||||||||||
Target & IC50 | P53 | ||||||||||||||||||||
Solubility | DMSO: 3.673 mg/mL (10 mM) | ||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20°C | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
Pifithrin-α is firstly found to block the activation of p53-responsive lacZ in ConA cells and reduce activation of endogenous cellular p53-responsive genes. In MEF cells transformed with E1a+ras, 10μM Pifithrin-α can inhibit the apoptosis of the cells and this anti-apoptotic activity is p53-dependent. Pifithrin-α also inhibits the growth arrest of human diploid fibroblasts induced by DNA damage but has no effect on p53-deficient fibroblasts. In addition, Pifithrin-α induces G2-arrest of cells after gamma irradiation. |
Specific Protocols | |